R Squared LTD Maxcyte, Inc. Call Options Transaction History
R Squared LTD
- $181 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MXCT
# of Institutions
122Shares Held
71.2MCall Options Held
0Put Options Held
0-
Cadian Capital Management, LP New York, NY8.91MShares$15.2 Million1.1% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$13.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY7.03MShares$12 Million0.0% of portfolio
-
Mirabella Financial Services LLP London, X06.6MShares$11.3 Million1.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$9.58 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $174M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...